QUIDELORTHO CORP Accounts Receivable, Allowance for Credit Loss, Writeoff
QUIDELORTHO CORP (QDEL) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $3.30 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › and Others › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2026-08-07
- QUIDELORTHO CORP accounts receivable, allowance for credit loss, writeoff for the quarter ending 2026-06-28 was $3.30M.
- QUIDELORTHO CORP accounts receivable, allowance for credit loss, writeoff for fiscal 2025 was $552.60M, a 15.51% increase from fiscal 2024.
- QUIDELORTHO CORP accounts receivable, allowance for credit loss, writeoff for fiscal 2024 was $478.40M, a 2.53% decline from fiscal 2023.
- QUIDELORTHO CORP accounts receivable, allowance for credit loss, writeoff for fiscal 2023 was $490.80M, a 32.33% increase from fiscal 2023.
- QUIDELORTHO CORP accounts receivable, allowance for credit loss, writeoff for fiscal 2023 was $370.90M, a 26.87% decline from fiscal 2022.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|
| 2026-06-28 | $3.30M 10-Q · filed 2026-08-07 | |
| 2025-12-28 | $552.60M 10-K · filed 2026-02-19 | |
| 2024-12-29 | $478.40M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $490.80M 10-K · filed 2026-02-19 | |
| 2023-01-01 | $370.90M 10-K · filed 2025-02-27 | |
| 2022-01-02 | $507.20M 10-K/A · filed 2024-08-01 | |
| 2021-01-03 | $189.50M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |